Regulatory T cells in arterivirus and coronavirus infections: Do they protect against disease or enhance it?

Viruses

Volumn 4, Issue 5, 2012, Pages 833-846

  Cecere, Thomas E ^a   Todd, S Michelle ^a   LeRoith, Tanya ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Arterivirus; Coronavirus; Lactate dehydrogenase elevating virus; Porcine reproductive and respiratory syndrome virus; Regulatory T cell

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ARTERIVIRUS INFECTION; CD4+ CD25+ T LYMPHOCYTE; CELL DENSITY; CORONAVIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFECTION RESISTANCE; LACTIC DEHYDROGENASE TOGAVIRUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION;

ANIMALS; ARTERIVIRUS; ARTERIVIRUS INFECTIONS; CORONAVIRUS; CORONAVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

ARTERIVIRUS; CORONAVIRUS; LACTATE DEHYDROGENASE-ELEVATING VIRUS; MURINE HEPATITIS VIRUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS;

EID: 84861553674     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v4050833     Document Type: Review

References (77)

1. Guckel, E.; Frey, S.; Zaiss, M.M.; Schett, G.; Ghosh, S.; Voll, R.E. Cell-intrinsic NF-kappaB activation is critical for the development of natural regulatory T cells in mice. PLoS One 2011, 6, e20003.
2. Bilate, A.M.; Lafaille, J.J. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 2012, 30, 733-758.
3. Bennett, C.L.; Christie, J.; Ramsdell, F.; Brunkow, M.E.; Ferguson, P.J.; Whitesell, L.; Kelly, T.E.; Saulsbury, F.T.; Chance, P.F.; Ochs, H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature genetics 2001, 27, 20-21.
4. Beissert, S.; Schwarz, A.; Schwarz, T. Regulatory T cells. J. Invest Dermatol. 2006, 126, 15-24.
5. Rouse, B.T.; Sarangi, P.P.; Suvas, S. Regulatory T cells in virus infections. Immunol. Rev. 2006, 212, 272-286.
6. LeRoith, T.; Hammond, S.; Todd, S.M.; Ni, Y.; Cecere, T.; Pelzer, K.D. A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae. Vet. Immunol. Immunopathol. 2011, 140, 312-316.
7. Zhao, J.; Fett, C.; Trandem, K.; Fleming, E.; Perlman, S. IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J. Exp. Med. 2011, 208, 1571-1577.
8. Sakaguchi, S.; Miyara, M.; Costantino, C.M.; Hafler, D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10, 490-500.
9. Thornton, A.M.; Shevach, E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 2000, 164, 183-190.
10. Sakaguchi, S. Regulatory T cells: Mediating compromises between host and parasite. Nat. Immunol. 2003, 4, 10-11.
11. Bacchetta, R.; Gregori, S.; Roncarolo, M.G. CD4+ regulatory T cells: Mechanisms of induction and effector function. Autoimmun. Rev. 2005, 4, 491-496.
12. Prots, I.; Skapenko, A.; Lipsky, P.E.; Schulze-Koops, H. Analysis of the transcriptional program of developing induced regulatory T cells. PLoS One 2011, 6, e16913.
13. Robertson, S.J.; Messer, R.J.; Carmody, A.B.; Hasenkrug, K.J. In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells. J. Immunol. 2006, 176, 3342-3349.
14. Belkaid, Y.; Rouse, B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6, 353-360.
15. Chang, Y.J.; Kim, H.Y.; Albacker, L.A.; Lee, H.H.; Baumgarth, N.; Akira, S.; Savage, P.B.; Endo, S.; Yamamura, T.; Maaskant, J.; et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J. Clin. Invest 2011, 121, 57-69.
16. Belkaid, Y. Regulatory T cells and infection: A dangerous necessity. Nat. Rev. Immunol. 2007, 7, 875-888.
17. Mexas, A.M.; Fogle, J.E.; Tompkins, W.A.; Tompkins, M.B. CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection. Vet. Immunol. Immunopathol. 2008, 126, 263-272.
18. Dittmer, U.; He, H.; Messer, R.J.; Schimmer, S.; Olbrich, A.R.; Ohlen, C.; Greenberg, P.D.; Stromnes, I.M.; Iwashiro, M.; Sakaguchi, S.; et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004, 20, 293-303.
19. Estes, J.D.; Li, Q.; Reynolds, M.R.; Wietgrefe, S.; Duan, L.; Schacker, T.; Picker, L.J.; Watkins, D.I.; Lifson, J.D.; Reilly, C.; et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect Dis. 2006, 193, 703-712.
20. Pereira, L.E.; Villinger, F.; Onlamoon, N.; Bryan, P.; Cardona, A.; Pattanapanysat, K.; Mori, K.; Hagen, S.; Picker, L.; Ansari, A.A. Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys. J. Virol. 2007, 81, 4445-4456.
21. Karlsson, I.; Malleret, B.; Brochard, P.; Delache, B.; Calvo, J.; Le Grand, R.; Vaslin, B. FoxP3+ CD25+ CD8+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load. J. Virol. 2007, 81, 13444-13455.
22. Boettler, T.; Spangenberg, H.C.; Neumann-Haefelin, C.; Panther, E.; Urbani, S.; Ferrari, C.; Blum, H.E.; von Weizsacker, F.; Thimme, R. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J. Virol. 2005, 79, 7860-7867.
23. Suvas, S.; Kumaraguru, U.; Pack, C.D.; Lee, S.; Rouse, B.T. CD4+CD25+ T cells regulate virusspecific primary and memory CD8+ T cell responses. J. Exp. Med. 2003, 198, 889-901.
24. Aandahl, E.M.; Michaelsson, J.; Moretto, W.J.; Hecht, F.M.; Nixon, D.F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 2004, 78, 2454-2459.
25. Marshall, N.A.; Vickers, M.A.; Barker, R.N. Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. J. Immunol. 2003, 170, 6183-6189.
26. Yang, G.; Liu, A.; Xie, Q.; Guo, T.B.; Wan, B.; Zhou, B.; Zhang, J.Z. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007, 19, 133-140.
27. Rossow, K.D. Porcine reproductive and respiratory syndrome. Vet. Pathol. 1998, 35, 1-20.
28. Riber, U.; Nielsen, J.; Lind, P. In utero infection with PRRS virus modulates cellular functions of blood monocytes and alveolar lung macrophages in piglets. Vet. Immunol. Immunopathol. 2004, 99, 169-177.
29. Rossow, K.D.; Collins, J.E.; Goyal, S.M.; Nelson, E.A.; Christopher-Hennings, J.; Benfield, D.A. Pathogenesis of porcine reproductive and respiratory syndrome virus infection in gnotobiotic pigs. Vet. Pathol. 1995, 32, 361-373.
30. Zeman, D.; Neiger, R.; Yaeger, M.; Nelson, E.; Benfield, D.; Leslie-Steen, P.; Thomson, J.; Miskimins, D.; Daly, R.; Minehart, M. Laboratory investigation of PRRS virus infection in three swine herds. J. Vet. Diagn. Invest. 1993, 5, 522-528.
31. Thacker, E.L.; Thacker, B.J.; Young, T.F.; Halbur, P.G. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae. Vaccine 2000, 18, 1244-1252.
32. Suradhat, S.; Kesdangsakonwut, S.; Sada, W.; Buranapraditkun, S.; Wongsawang, S.; Thanawongnuwech, R. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. Vaccine 2006, 24, 2634-2642.
33. Meier, W.A.; Galeota, J.; Osorio, F.A.; Husmann, R.J.; Schnitzlein, W.M.; Zuckermann, F.A. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 2003, 309, 18-31.
34. Wesley, R.D.; Lager, K.M.; Kehrli, M.E., Jr. Infection with Porcine reproductive and respiratory syndrome virus stimulates an early gamma interferon response in the serum of pigs. Can. J. Vet. Res. 2006, 70, 176-182.
35. Xiao, Z.; Batista, L.; Dee, S.; Halbur, P.; Murtaugh, M.P. The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. J. Virol. 2004, 78, 5923-5933.
36. Lopez, O.J.; Osorio, F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet. Immunol. Immunopathol. 2004, 102, 155-163.
37. Diaz, I.; Darwich, L.; Pappaterra, G.; Pujols, J.; Mateu, E. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology 2006, 351, 249-259.
38. Martelli, P.; Gozio, S.; Ferrari, L.; Rosina, S.; De Angelis, E.; Quintavalla, C.; Bottarelli, E.; Borghetti, P. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity. Vaccine 2009, 27, 3788-3799.
39. Silva-Campa, E.; Flores-Mendoza, L.; Resendiz, M.; Pinelli-Saavedra, A.; Mata-Haro, V.; Mwangi, W.; Hernandez, J. Induction of T helper 3 regulatory cells by dendritic cells infected with porcine reproductive and respiratory syndrome virus. Virology 2009, 387, 373-379.
40. Charerntantanakul, W.; Platt, R.; Roth, J.A. Effects of porcine reproductive and respiratory syndrome virus-infected antigen-presenting cells on T cell activation and antiviral cytokine production. Viral Immunol. 2006, 19, 646-661.
41. Suradhat, S.; Thanawongnuwech, R. Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2003, 84, 2755-2760.
42. Feng, W.H.; Tompkins, M.B.; Xu, J.S.; Zhang, H.X.; McCaw, M.B. Analysis of constitutive cytokine expression by pigs infected in-utero with porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2003, 94, 35-45.
43. Gomez-Laguna, J.; Salguero, F.J.; Barranco, I.; Pallares, F.J.; Rodriguez-Gomez, I.M.; Bernabe, A.; Carrasco, L. Cytokine expression by macrophages in the lung of pigs infected with the porcine reproductive and respiratory syndrome virus. J. Comp. Pathol. 2010, 142, 51-60.
44. Subramaniam, S.; Sur, J.H.; Kwon, B.; Pattnaik, A.K.; Osorio, F.A. A virulent strain of porcine reproductive and respiratory syndrome virus does not up-regulate interleukin-10 levels in vitro or in vivo. Virus Res. 2011, 155, 415-422.
45. Gimeno, M.; Darwich, L.; Diaz, I.; de la Torre, E.; Pujols, J.; Martin, M.; Inumaru, S.; Cano, E.; Domingo, M.; Montoya, M.; et al. Cytokine profiles and phenotype regulation of antigen presenting cells by genotype-I porcine reproductive and respiratory syndrome virus isolates. Vet. Res. 2011, 42, 9.
46. Darwich, L.; Gimeno, M.; Sibila, M.; Diaz, I.; de la Torre, E.; Dotti, S.; Kuzemtseva, L.; Martin, M.; Pujols, J.; Mateu, E. Genetic and immunobiological diversities of porcine reproductive and respiratory syndrome genotype I strains. Vet. Microbiol. 2011, 150, 49-62.
47. Enk, A.H. Dendritic cells in tolerance induction. Immunol. Lett. 2005, 99, 8-11.
48. Fiorentino, D.F.; Zlotnik, A.; Mosmann, T.R.; Howard, M.; O'Garra, A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147, 3815-3822.
49. Gazzinelli, R.T.; Oswald, I.P.; James, S.L.; Sher, A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 1992, 148, 1792-1796.
50. Carter, Q.L.; Curiel, R.E. Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection. Vet. Immunol. Immunopathol. 2005, 107, 105-118.
51. Vicari, A.P.; Trinchieri, G. Interleukin-10 in viral diseases and cancer: Exiting the labyrinth? Immunol. Rev. 2004, 202, 223-236.
52. Silva-Campa, E.; Cordoba, L.; Fraile, L.; Flores-Mendoza, L.; Montoya, M.; Hernandez, J. European genotype of porcine reproductive and respiratory syndrome (PRRSV) infects monocyte-derived dendritic cells but does not induce Treg cells. Virology 2010, 396, 264-271.
53. Wongyanin, P.; Buranapraditkun, S.; Chokeshai-Usaha, K.; Thanawonguwech, R.; Suradhat, S. Induction of inducible CD4+CD25+Foxp3+ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV). Vet. Immunol. Immunopathol. 2010, 133, 170-182.
54. Wongyanin, P.; Buranapraditkul, S.; Yoo, D.; Thanawongnuwech, R.; Roth, J.A.; Suradhat, S. The role of porcine reproductive and respiratory syndrome virus (PRRSV) nucleocapsid protein for induction of IL-10 and regulatory T lymphocytes (Treg). J. Gen. Virol. 2012.
55. Dwivedi, V.; Manickam, C.; Patterson, R.; Dodson, K.; Murtaugh, M.; Torrelles, J.B.; Schlesinger, L.S.; Renukaradhya, G.J. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant. Vaccine 2011, 29, 4058-4066.
56. Dwivedi, V.; Manickam, C.; Patterson, R.; Dodson, K.; Weeman, M.; Renukaradhya, G.J. Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs. Vaccine 2011, 29, 4067-4076.
57. Dwivedi, V.; Manickam, C.; Binjawadagi, B.; Linhares, D.; Murtaugh, M.P.; Renukaradhya, G.J. Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions. Virol. J. 2012, 9, 45.
58. Yuan, S.; Mickelson, D.; Murtaugh, M.P.; Faaberg, K.S. Complete genome comparison of porcine reproductive and respiratory syndrome virus parental and attenuated strains. Virus Res. 2001, 79, 189-200.
59. Mateu, E.; Diaz, I. The challenge of PRRS immunology. Vet. J. 2008, 177, 345-351.
60. Plagemann, P.G.; Rowland, R.R.; Even, C.; Faaberg, K.S. Lactate dehydrogenase-elevating virus: An ideal persistent virus? Springer Semin. Immunopathol. 1995, 17, 167-186.
61. Rowson, K.E.; Mahy, B.W. Lactate dehydrogenase-elevating virus. J. Gen. Virol. 1985, 66, 2297-2312.
62. Rowland, R.R.; Even, C.; Anderson, G.W.; Chen, Z.; Hu, B.; Plagemann, P.G. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. J Gen Virol 1994, 75, 1071-1081.
63. Inada, T.; Mims, C.A. Live lactate dehydrogenase-elevating virus (LDV) induces suppressor T cells that inhibit the development of delayed hypersensitivity to LDV. J. Gen. Virol. 1986, 67, 2103-2112.
64. Askenase, P.W.; Hayden, B.J.; Gershon, R.K. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J. Exp. Med. 1975, 141, 697-702.
65. Mitsuoka, A.; Baba, M.; Morikawa, S. Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice. Nature 1976, 262, 77-78.
66. Robertson, S.J.; Ammann, C.G.; Messer, R.J.; Carmody, A.B.; Myers, L.; Dittmer, U.; Nair, S.; Gerlach, N.; Evans, L.H.; Cafruny, W.A.; et al. Suppression of acute anti-friend virus CD8+ Tcell responses by coinfection with lactate dehydrogenase-elevating virus. J. Virol. 2008, 82, 408-418.
67. Isakov, N.; Feldman, M.; Segal, S. Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. Cell Immunol. 1982, 66, 317-332.
68. Li, S.; Gowans, E.J.; Chougnet, C.; Plebanski, M.; Dittmer, U. Natural regulatory T cells and persistent viral infection. J. Virol. 2008, 82, 21-30.
69. Anghelina, D.; Pewe, L.; Perlman, S. Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis. Am J Pathol 2006, 169, 209-222.
70. Anghelina, D.; Zhao, J.; Trandem, K.; Perlman, S. Role of regulatory T cells in coronavirusinduced acute encephalitis. Virology 2009, 385, 358-367.
71. Bergmann, C.C.; Parra, B.; Hinton, D.R.; Ramakrishna, C.; Dowdell, K.C.; Stohlman, S.A. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J. Virol. 2004, 78, 1739-1750.
72. Wang, F.I.; Stohlman, S.A.; Fleming, J.O. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 1990, 30, 31-41.
73. Wu, G.F.; Dandekar, A.A.; Pewe, L.; Perlman, S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 2000, 165, 2278-2286.
74. Trandem, K.; Anghelina, D.; Zhao, J.; Perlman, S. Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J. Immunol. 2010, 184, 4391-4400.
75. Fleming, J.O.; Trousdale, M.D.; el-Zaatari, F.A.; Stohlman, S.A.; Weiner, L.P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 1986, 58, 869-875.
76. Bergmann, C.C.; Lane, T.E.; Stohlman, S.A. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat. Rev. Microbiol. 2006, 4, 121-132.
77. Shalev, I.; Wong, K.M.; Foerster, K.; Zhu, Y.; Chan, C.; Maknojia, A.; Zhang, J.; Ma, X.Z.; Yang, X.C.; Gao, J.F.; et al. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 2009, 49, 387-397